Guiyang Xintian Pharmaceutical Co.,Ltd. (SZSE: 002873)
Health Care · Pharmaceuticals · CN
CN¥8.55
+2.03% today · -19.0% 1Y
Guiyang Xintian Pharmaceutical Co.,Ltd. (SZSE: 002873) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $303.03M and employs 1,388 people.
Over the last twelve months the share price has lost 19.0%, trading between 7.04 and 13.09.
Tweenvest scores Guiyang Xintian Pharmaceutical Co.,Ltd. across four factors: quality 69/100, value 34/100, growth 0/100, dividend 22/100. Its strongest factor is quality.
002873 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $303.03M
- Revenue (TTM)
- $106.47M
- P/E
- 240.95
- EPS
- 0.04
- Dividend yield
- 0.35%
- Beta (5Y)
- 0.01
- 52-week high
- CN¥13.09
- 52-week low
- CN¥7.04
- Avg volume (3M)
- —
- Shares outstanding
- 237.74M
- Employees
- 1,388
- Next earnings
- —
About Guiyang Xintian Pharmaceutical Co.,Ltd.
Guiyang Xintian Pharmaceutical Co.,Ltd. is a Chinese company dedicated to the research, development, production, and commercialization of traditional Chinese medicines (TCMs) for a wide range of ailments. Its product offerings include various pharmaceutical formulations such as hard capsules, gels, mixtures, granules, and tablets. These medicines are specifically designed to treat diverse medical conditions, including antitumor applications, gynecological issues, urinary tract problems, breast and thyroid disorders, blood-related illnesses, heat-related syndromes, oral health complaints, common colds, and cardiovascular diseases. The company was founded in 1995 and is headquartered in Guiyang, China.
- ISIN
- CNE100002QB5
- Founded
- 1995
- Listed since
- May 19, 2017
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,LtdSZSE: 301130 | $320.87M | CN¥28.51 | +1.14% |
| EI- Nile Co. for Pharmaceuticals and Chemical IndustriesCASE: NIPH | $316.17M | EGP331.03 | +1.70% |
| Standard Chemical & Pharmaceutical Co., Ltd.TWSE: 1720 | $314.56M | NT$56.10 | +0.36% |
| SNDL Inc.NasdaqCM: SNDL | $308.34M | $1.22 | -1.61% |
| Lavipharm S.A.ATSE: LAVI | $301.39M | €1.57 | -0.13% |
| Bukwang Pharmaceutical Co., Ltd.KOSE: A003000 | $300.37M | ₩4,100.00 | +4.33% |
| Zhejiang Benli Technology Co., Ltd.SZSE: 301065 | $300.03M | CN¥20.06 | +0.55% |
| Biofarm S.A.BVB: BIO | $299.92M | RON— | — |
Figures last refreshed Oct 4, 2026.